{"paper_id":"89a5fe41-dc04-4cff-96b5-c0d9dabd1e58","body_text":"Published online by Cambridge University Press: 24 April 2007\nBackground\nEstrogen has been hypothesized to have a protective and antipsychotic-like effect in women at risk for schizophrenia. The aim of the present study was to evaluate the association between menstrual cycle and/or estrogen levels and psychotic symptoms in a sample of women with schizophrenia.\nMethod\nOne hundred and twenty-five premenopausal women with schizophrenia and regular menses were examined. The levels of 17β-estradiol and other hormones of the gonadal axis were assessed in the follicular, peri-ovulatory, and luteal phases of the menstrual cycle. The effects of the menstrual cycle phase and/or the estradiol level on the Positive and Negative Syndrome Scale (PANSS) and the Brief Psychiatric Rating Scale (BPRS) scores were calculated by means of regression analyses.\nResults\nSignificant improvement in psychotic, but not depressive, symptoms was observed during the luteal phase, compared with other days of the menstrual cycle.\nConclusions\nThe present findings indicate that estradiol may have specific antipsychotic-like effects on the symptoms of schizophrenia. Thus further investigation into the therapeutic effect of estrogen may be worthwhile.\n- Type\n- Original Article\n- Information\n- Copyright\n- Copyright © Cambridge University Press 2007\nAbe, K. & Ohta, M. (1998). Recurrent brief episodes with psychotic features in adolescence: periodic psychosis of puberty revisited. Psychiatry and Clinical Neurosciences 52, 313–316.CrossRefGoogle ScholarPubMed\nAkhondzadeh, S., Nejatisafa, A. A., Amini, H., Mohammadi, M. R., Larijani, B. & Kashani, L. (2003). Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. Progress in Neuropsychopharmacology and Biological Psychiatry 27, 1007–1012.CrossRefGoogle ScholarPubMed\nAltschule, M. D. & Brem, J. (1963). Periodic psychosis of puberty. American Journal of Psychiatry 6, 1176–1178.CrossRefGoogle Scholar\nAmbelas, A. (1994). Cyclic psychosis, menstrual cycle and adolescence. British Journal of Psychiatry 164, 709.CrossRefGoogle ScholarPubMed\nBehl, C. (2001). Estrogens – Mystery Drug for the Brain. The Neuroprotective Activities of the Female Sex Hormone. Springer: Wien, New York.Google Scholar\nBehl, C. (2003). Neuroprotective effects of estrogens in the central nervous system: mechanisms of action. In Risk and Protective Factors in Schizophrenia. Towards a Conceptual Model of the Disease Process (ed. Häfner, H.). Steinkopff: Darmstadt, Germany.Google Scholar\nBergemann, N. & Riecher-Rössler, A. (eds) (2005). Estrogen Effects in Psychiatric Disorders. Springer: New York.CrossRefGoogle Scholar\nBergemann, N., Abu-Tair, F. & Strowitzki, T. (in press). Estrogen in the treatment of late-onset schizophrenia. Journal of Clinical Psychopharmacology.Google Scholar\nBergemann, N., Mundt, C., Parzer, P., Nagl, I., Eckstein-Mannsperger, U., Haisch, S., Salbach, B., Runnebaum, B. & Resch, F. (2005 a). Plasma concentration of estradiol in women suffering from schizophrenia treated with conventional and atypical antipsychotics. Schizophrenia Research 73, 357–366.CrossRefGoogle ScholarPubMed\nBergemann, N., Mundt, C., Parzer, P., Pakrasi, M., Eckstein-Mannsperger, U., Haisch, S., Salbach, B., Klinga, K., Runnebaum, B. & Resch, F. (2005 b). Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double blind study. Schizophrenia Research 74, 125–134.CrossRefGoogle Scholar\nBergemann, N., Parzer, P., Nagl, I., Salbach, B., Runnebaum, B., Mundt, C. & Resch, F. (2002). Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Archives of Women's Mental Health 5, 119–126.CrossRefGoogle ScholarPubMed\nBerlin, F. S., Bergey, G. K. & Money, J. (1982). Periodic psychosis of puberty: a case report. American Journal of Psychiatry 139, 119–120.Google ScholarPubMed\nBrockington, I. F., Kelly, A. & Hall, P. (1988). Premenstrual relapse of puerperal psychosis. Journal of Affective Disorder 14, 287–292.CrossRefGoogle ScholarPubMed\nChang, S. S. & Renshaw, D. C. (1986). Psychosis and pregnancy. Comprehensive Therapy 12, 36–41.Google ScholarPubMed\nChua, W. L., Izquierdo de Santiago, A., Kulkarni, J. & Mortimer, A. (2005). Estrogens for schizophrenia. The Cochrane Database of Systematic Reviews 19(4), CD004719.Google Scholar\nCyr, M., Calon, F., Morissette, M. & Di Paolo, T. (2002). Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. Journal of Psychiatry and Neuroscience 27, 12–27.Google ScholarPubMed\nDennerstein, L., Judd, F. & Davies, B. (1983). Psychosis and the menstrual cycle. Medical Journal of Australia 1, 524–526.CrossRefGoogle ScholarPubMed\nDiPaolo, T. (1994). Modulation of brain dopamine transmission by sex steroids. Review of the Neurosciences 5, 27–41.Google Scholar\nEndo, M., Daiguji, M., Asano, Y., Yamashita, I. & Takahashi, S. (1978). Periodic psychosis in association with menstrual cycle. Journal of Clinical Psychiatry 39, 456–466.Google ScholarPubMed\nErler, K. (1998). Elecsys immunoassay systems using electrochemiluminescence detection. Wiener Klinische Wochenschrift 110 (suppl. 3), 5–9.Google ScholarPubMed\nFelthous, A. R., Robinson, D. B. & Conroy, R. W. (1980). Prevention of recurrent menstrual psychosis by an oral contraceptive. American Journal of Psychiatry 137, 245–246.Google ScholarPubMed\nFink, G., Sumner, B. E. H., McQueen, J. K., Wilson, H. & Rosie, R. (1998). Sex steroid control of mood, mental state and memory. Clinical and Experimental Pharmacology and Physiology 25, 764–775.CrossRefGoogle ScholarPubMed\nFink, G., Sumner, B. E. H., Rosie, R., Grace, O. & Quinn, J. P. (1996). Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cellular and Molecular Neurobiology 16, 325–344.CrossRefGoogle ScholarPubMed\nGarcia-Segura, L. M., Azcoitia, I. & DonCarlos, L. L. (2001). Neuroprotection by estradiol. Progress in Neurobiology 63, 29–60.CrossRefGoogle ScholarPubMed\nGattaz, W. F., Vogel, P., Riecher-Rössler, A. & Soddu, G. (1994). Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biological Psychiatry 36, 137–139.CrossRefGoogle ScholarPubMed\nGerada, C. & Reveley, A. (1988). Schizophreniform psychosis associated with menstrual cycle. British Journal of Psychiatry 152, 700–712.CrossRefGoogle ScholarPubMed\nGlick, I. D. & Stewart, D. (1980). A new drug treatment for premenstrual exacerbation of schizophrenia. Comprehensive Psychiatry 21, 281–287.CrossRefGoogle ScholarPubMed\nGood, K. P., Kopola, L. C., Martzke, J. S., Fluker, M., Seeman, M. V., Parish, B., Shapiro, H. & Whitehorne, L. (1999). Hormone replacement therapy in postmenopausal women with schizophrenia: preliminary findings. Schizophrenia Research 36, 131.Google Scholar\nGordon, J. H., Borison, R. L. & Diamond, B. I. (1980). Modulation of dopamine receptor sensitivity by estrogen. Biological Psychiatry 15, 389–396.Google ScholarPubMed\nHalbreich, U. (2002). The spectrum of estrogens, estrogen agonists and SERMS. International Journal of Neuropsychopharmacology 5 (Suppl. 1), 12.Google Scholar\nHalbreich, U., Rojansky, N., Palter, S., Tworek, H., Hissin, P. & Wang, K. (1995). Estrogen augments serotonergic activity in postmenopausal women. Biological Psychiatry 37, 434–441.CrossRefGoogle ScholarPubMed\nHallonquist, J. D., Seeman, M. V., Lang, M. & Rector, N. A. (1993). Variation in symptom severity over the menstrual cycle of schizophrenics. Biological Psychiatry 33, 207–209.CrossRefGoogle ScholarPubMed\nHammarback, S., Backstrom, T., Holst, J., von Schoultz, B. & Lyrenas, S. (1985). Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstetricia et Gynecologica Scandinavica 64, 393–397.CrossRefGoogle ScholarPubMed\nHarris, A. H. (1997). Menstrually related symptom changes in women with schizophrenia. Schizophrenia Research 27, 93–99.CrossRefGoogle ScholarPubMed\nHendrick, V., Altshuler, L. L. & Burt, V. K. (1996). Course of psychiatric disorders across the menstrual cycle. Harvard Review of Psychiatry 4, 200–207.CrossRefGoogle ScholarPubMed\nHopker, S. W. & Brockington, I. F. (1991). Psychosis following hydatidiform mole in patient with recurrent puerperal psychosis. British Journal of Psychiatry 158, 122–123.CrossRefGoogle ScholarPubMed\nJolly, Ph. (1915). Menstruation und Psychose. Archiv für Psychiatrie und Nervenkrankheiten 55, 637–686.CrossRefGoogle Scholar\nKay, S. R., Fiszbein, A. & Opler, L. A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.CrossRefGoogle ScholarPubMed\nKendell, R. E., Chalmers, J. C. & Platz, C. (1987). Epidemiology of puerperal psychoses. British Journal of Psychiatry 150, 662–673.CrossRefGoogle ScholarPubMed\nKlinga, K. (1997). Determination of hormones and hormone receptors. In Gynecological Endocrinology and Reproductive Medicine, Vol. 1 (ed. Runnebaum, B. and Rabe, T.), pp. 45–54. Springer: Heidelberg, Berlin, New York.CrossRefGoogle Scholar\nKrafft-Ebing, R. v. (1878). Untersuchungen über das Irresein zur Zeit der Menstruation. Archiv für Psychiatrie und Nervenkrankheiten 8, 65–107.CrossRefGoogle Scholar\nKulkarni, J. (2005). Clinical estrogen trials in patients with schizophrenia. In Estrogen Effects in Psychiatric Disorders (ed. Bergemann, N. and Riecher-Rössler, A.), pp. 107–122. Springer: New York.CrossRefGoogle Scholar\nKulkarni, J., deCastella, A., Riedel, A., Taffe, J., Fitzgerald, P. & Burger, H. (2001). Estrogen – a potential new treatment in schizophrenia. Schizophrenia Research 48, 137–144.CrossRefGoogle Scholar\nKulkarni, J., deCastella, A., Smith, D., Taffe, J., Keks, N. & Copolov, D. (1996). A clinical trial of the effects of estrogen in acutely psychotic women. Schizophrenia Research 20, 247–252.CrossRefGoogle ScholarPubMed\nLee, S. J. & McEwen, B. S. (2001). Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annual Review of Pharmacology and Toxicology 41, 569–591.CrossRefGoogle ScholarPubMed\nLeidenberger, F. A. (1992). Klinische Endokrinologie für Frauenärzte. Springer, Berlin.CrossRefGoogle Scholar\nLindamer, L. A., Buse, D. C., Lohr, J. B. & Jeste, D. V. (2001). Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biological Psychiatry 49, 47–51.CrossRefGoogle ScholarPubMed\nLouzã, M. R., Marques, A. P., Elkis, H., Bassitt, D., Diegoli, M. & Gattaz, W. F. (2004). Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study. Schizophrenia Research 66, 97–100.CrossRefGoogle ScholarPubMed\nLovestone, S. (1993). Periodic psychosis associated with the menstrual cycle and childbirth. British Journal of Psychiatry 162, 424–425.CrossRefGoogle ScholarPubMed\nMagharious, W., Goff, D. C. & Amico, E. (1998). Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatry Research 77, 159–166.CrossRefGoogle ScholarPubMed\nMahé, V. & Dumaine, A. (2001). Oestrogen withdrawal associated psychoses. Acta Psychiatrica Scandinavica 104, 323–331.CrossRefGoogle ScholarPubMed\nMajewska, M. D. (1992). Neurosteroids: endogenous bimodal modulators of the GABA-A receptor. Mechanism of action and physiological significance. Progress in Neurobiology 38, 379–395.CrossRefGoogle ScholarPubMed\nMcEwen, B. S. & Alvers, S. E. (1999). Estrogen actions in the central nervous system. Endocrine Reviews 20, 279–307.Google ScholarPubMed\nMorissette, M. & DiPaolo, T. (1993). Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 58, 16–22.CrossRefGoogle ScholarPubMed\nNorth American Menopause Society (2003). Estrogen and progestogen use in peri- and postmenopausal women: September 2003 position statement of The North American Menopause Society. Menopause 10, 497–506.CrossRefGoogle Scholar\nNotman, M. T. & Nadelson, C. C. (2002). The hormone replacement therapy controversy. Archives of Women's Mental Health 5, 33–35.CrossRefGoogle ScholarPubMed\nOverall, J. E. & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports 10, 799–812.CrossRefGoogle Scholar\nRabe, T. & Runnebaum, B. (1997). Hormones. In Gynecological Endocrinology and Reproductive Medicine, Vol. 1 (ed. Runnebaum, B. and Rabe, T.), pp. 1–43. Springer: Heidelberg, Berlin, New York.Google Scholar\nRabe-Hesketh, S. & Skrondal, A. (2005). Multilevel and Longitudinal Modeling Using Stata. Stata Press: College Station, TX.Google Scholar\nRey, M. J, Schulz, P., Costa, C., Dick, P. & Tissot, R. (1989). Guidelines for the dosage of neuroleptics 1: chlorpromazine equivalents of orally administered neuroleptics. International Clinical Psychopharmacology 4, 95–104.CrossRefGoogle Scholar\nRiecher-Rössler, A. (2005). Estrogens effects in schizophrenia – update and potential therapeutic implications. In Estrogen Effects in Psychiatric Disorders (ed. Bergemann, N. and Riecher-Rössler, A.), pp. 31–52. Springer: New York.CrossRefGoogle Scholar\nRiecher-Rössler, A., Häfner, H., Dütsch-Strobel, A. & Stumbaum, M. (1998). Gonadal function and its influence on psychopathology – a comparison of schizophrenic and non-schizophrenic female inpatients. Archives of Women's Mental Health 1, 15–26.CrossRefGoogle Scholar\nRiecher-Rössler, A., Häfner, H., Stumbaum, M., Maurer, K. & Schmidt, R. (1994). Can estradiol modulate schizophrenic symptomatology? Schizophrenia Bulletin 20, 203–214.CrossRefGoogle ScholarPubMed\nSchaefer, A. (1894). Einfluss der Psychose auf den Menstruationsvorgang. Allgemeine Zeitschrift für Psychiatrie 50, 976–996.Google Scholar\nSchroeter, R. (1874). Die Menstruation in ihren Beziehungen zu den Psychosen. Zeitschrift für Psychiatrie 30 (part I), 551–572; 31 (part II), 234–250.Google Scholar\nSeeman, M. V. (1983). Interaction of sex, age, and neuroleptic dose. Comprehensive Psychiatry 24, 125–128.CrossRefGoogle ScholarPubMed\nSeeman, M. V. (1997). Psychopathology in women and men: focus on female hormones. American Journal of Psychiatry 154, 1641–1647.CrossRefGoogle ScholarPubMed\nSeverino, S. K. & Yonkers, K. A. (1993). A literature review of psychotic symptoms associated with the premenstruum. Psychosomatics 34, 299–306.CrossRefGoogle ScholarPubMed\nStata Corporation (2005). Stata Statistical Software: Release 9.1. Stata Corporation: College Station, TX.Google Scholar\nStein, D., Hanukoglu, A., Blank, S. & Elizur, A. (1993). Cyclic psychosis associated with the menstrual cycle. British Journal of Psychiatry 163, 824–828.CrossRefGoogle ScholarPubMed\nSwanson, D. W., Barron, A., Floren, A. & Smith, J. A. (1964). The use of norethynodrel in psychotic females. American Journal of Psychiatry 120, 1101–1103.CrossRefGoogle ScholarPubMed\nTeja, J. S. (1976). Periodic psychosis of puberty. A longitudinal case study. Journal of Nervous and Mental Disease 162, 52–57.CrossRefGoogle ScholarPubMed\nWoods, S. W. (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry 64, 663–667.CrossRefGoogle ScholarPubMed\nWriting Group for the Women's Health Initiative Investigators (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288, 321–333.CrossRefGoogle Scholar\nWriting Group of the International Menopause Society Executive Committee (2004). Guidelines for the hormone treatment of women in the menopause transition and beyond. Position Statement by the Executive Committee of the International Menopause Society. Climacteric 7, 8–11.CrossRefGoogle Scholar\n- 111\n- Cited by\nCited by\nCrossref Citations\nBergemann, Niels\nAbu-Tair, Fatima\nand\nStrowitzki, Thomas\n2007.\nEstrogen in the Treatment of Late-Onset Schizophrenia.\nJournal of Clinical Psychopharmacology,\nVol. 27,\nIssue. 6,\np.\n717.\ndi Michele, Flavia\nCaltagirone, Carlo\nand\nSpalletta, Gianfranco\n2008.\nNeuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders.\np.\n325.\nKulkarni, Jayashri\nGurvich, Caroline\nGilbert, Heather\nMehmedbegovic, Fatima\nMu, Ling\nMarston, Natasha\nGavrilidis, Emmy\nand\nde Castella, Anthony\n2008.\nHormone Modulation: A Novel Therapeutic Approach for Women with Severe Mental Illness.\nAustralian & New Zealand Journal of Psychiatry,\nVol. 42,\nIssue. 1,\np.\n83.\nArad, Michal\nand\nWeiner, Ina\n2008.\nFluctuation of latent inhibition along the estrous cycle in the rat: Modeling the cyclicity of symptoms in schizophrenic women?.\nPsychoneuroendocrinology,\nVol. 33,\nIssue. 10,\np.\n1401.\nBergemann, N.\nParzer, P.\nJaggy, S.\nAuler, B.\nMundt, C.\nand\nMaier-Braunleder, S.\n2008.\nEstrogen and Comprehension of Metaphoric Speech in Women Suffering From Schizophrenia: Results of a Double-Blind, Placebo-Controlled Trial.\nSchizophrenia Bulletin,\nVol. 34,\nIssue. 6,\np.\n1172.\nBergemann, N.\nParzer, P.\nMundt, C.\nand\nAuler, B.\n2008.\nHigh bone turnover but normal bone mineral density in women suffering from schizophrenia.\nPsychological Medicine,\nVol. 38,\nIssue. 8,\np.\n1195.\nWestheide, Jens\nCvetanovska, Gabriele\nAlbrecht, Carsten\nBliesener, Niclaas\nCooper-Mahkorn, Déirdre\nCreutz, Cornelia\nHornung, Wolfgang-Peter\nKlingmüller, Dietrich\nLemke, Matthias R.\nMaier, Wolfgang\nSchubert, Michaela\nSträter, Birgitta\nand\nKühn, Kai-Uwe\n2008.\nProlactin, Subjective Well-Being and Sexual Dysfunction: An Open Label Observational Study Comparing Quetiapine with Risperidone.\nThe Journal of Sexual Medicine,\nVol. 5,\nIssue. 12,\np.\n2816.\nBrown, J. S.\n2009.\nEffects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia.\nSchizophrenia Bulletin,\nVol. 35,\nIssue. 1,\np.\n256.\nYip, Sarah W.\nSacco, Kristi A.\nGeorge, Tony P.\nand\nPotenza, Marc N.\n2009.\nRisk/reward decision-making in schizophrenia: A preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance.\nSchizophrenia Research,\nVol. 110,\nIssue. 1-3,\np.\n156.\nRubin, Leah H.\nCarter, C. Sue\nDrogos, Lauren\nPournajafi-Nazarloo, Hossein\nSweeney, John A.\nand\nMaki, Pauline M.\n2010.\nPeripheral oxytocin is associated with reduced symptom severity in schizophrenia.\nSchizophrenia Research,\nVol. 124,\nIssue. 1-3,\np.\n13.\nRiecher-Rössler, Anita\nand\nKulkarni, Jayashri\n2010.\nBiological Basis of Sex Differences in Psychopharmacology.\nVol. 8,\nIssue. ,\np.\n155.\nMendrek, Adrianna\nand\nStip, Emmanuel\n2011.\nSexual dimorphism in schizophrenia: is there a need for gender-based protocols?.\nExpert Review of Neurotherapeutics,\nVol. 11,\nIssue. 7,\np.\n951.\nBellem, Astrid\nMeiyappan, Soumia\nRomans, Sarah\nand\nEinstein, Gillian\n2011.\nMeasuring Estrogens and Progestagens in Humans: An Overview of Methods.\nGender Medicine,\nVol. 8,\nIssue. 5,\np.\n283.\nKulkarni, Jayashri\nde Castella, Anthony\nHeadey, Barbara\nMarston, Natasha\nSinclair, Kelly\nLee, Stuart\nGurvich, Caroline\nFitzgerald, Paul B.\nand\nBurger, Henry\n2011.\nEstrogens and men with schizophrenia: Is there a case for adjunctive therapy?.\nSchizophrenia Research,\nVol. 125,\nIssue. 2-3,\np.\n278.\nKulkarni, Jayashri\nand\nGavrilidis, Emmy\n2011.\nEstrogen as an adjunctive treatment approach for managing schizophrenia.\nPsychiatrie und Psychotherapie,\nVol. 7,\nIssue. 4,\np.\n124.\nBergemann, N.\n2011.\nHormontherapie und schizophrene Psychosen.\nGynäkologische Endokrinologie,\nVol. 9,\nIssue. 1,\np.\n24.\nSeeman, M. V.\n2012.\nMenstrual exacerbation of schizophrenia symptoms.\nActa Psychiatrica Scandinavica,\nVol. 125,\nIssue. 5,\np.\n363.\nBegemann, Marieke J.H.\nDekker, Caroline F.\nvan Lunenburg, Mari\nand\nSommer, Iris E.\n2012.\nEstrogen augmentation in schizophrenia: A quantitative review of current evidence.\nSchizophrenia Research,\nVol. 141,\nIssue. 2-3,\np.\n179.\nMarkham, Julie A.\n2012.\nSex steroids and schizophrenia.\nReviews in Endocrine and Metabolic Disorders,\nVol. 13,\nIssue. 3,\np.\n187.\nKulkarni, Jayashri\nHayes, Emily\nand\nGavrilidis, Emmy\n2012.\nHormones and schizophrenia.\nCurrent Opinion in Psychiatry,\nVol. 25,\nIssue. 2,\np.\n89.","source_license":"CC0","license_restricted":false}